HLA-A Genotyping for Defined Immunology Research
Human Leukocyte Antigen (HLA) class I molecules play a fundamental role in antigen presentation, immune recognition, and T-cell response. When donor HLA status is uncharacterized, donor variability can introduce significant confounding factors in immunological and translational studies.
Instead of purchasing random donors and performing expensive, time-consuming HLA screening in-house, researchers can immediately obtain donor lots with known HLA-A genotypes. This approach accelerates experimental planning, shortens time-to-data, and removes guesswork from donor selection.
These genotype-defined primary cell lots enable researchers to minimize donor variability, ensure major histocompatibility antigen matching, and accelerate target validation in cell therapy and T-cell receptor (TCR) discovery across defined experimental models.
Featured HLA-A Alleles
Selected primary human cell lots carry confirmed high-resolution genotypes for major HLA-A alleles:
A widely studied allele for investigating peptide-specific T-cell recognition and immune responses.
A common allele for studying allele-specific peptide presentation and T-cell recognition.
A clinically relevant allele for investigating peptide presentation and T-cell-mediated immune responses.
Improve Donor Matching and Experimental Consistency
Selecting donor lots with known HLA-A genotypes directly addresses the logistical and scientific challenges of donor matching in immunology workflows:
Pre-typed donor lots
Immediately access donor lots characterized for common HLA-A alleles without in-house screening delays.
Reduce project costs & save screening time
Avoid purchasing multiple uncharacterized donor lots and eliminate routine preliminary genotyping expenses, saving weeks of screening.
Ensure histocompatibility antigen matching
Minimize donor variability and establish defined donor-matched cellular models for immune assays.
Primary human cell context
Evaluate immune interactions, antigen presentation, and cellular toxicity in authentic primary human cells.
Accelerate translational research
Shorten time-to-data and streamline target validation for TCR discovery, CAR-T, and cell therapy development.
Support structured experimental design
Incorporate confirmed HLA genetic backgrounds as intentional parameters in vaccine and personalized medicine studies.
From HLA Genotype Selection to Functional Studies
Pre-genotyped primary human cells support a range of translational immunology and immuno-oncology applications:
HLA Genotype-Defined Primary Cells
Our inventory of HLA-genotyped primary cells is organized by cell type and continuously updated. Product availability may change without prior notice.
For information on additional HLA genotype options (such as HLA-B or HLA-C loci), current inventory, or specific product inquiries, please contact our technical team.
Interested in a Specific HLA Genotype?
Follow these steps to request genotype-defined donor lots for your study:
Identify the Cell Type
Identify the required primary human cell type for your research.
Specify HLA Genotype
Specify the required HLA-A allele or genotype (e.g., HLA-A*02:01, HLA-A*03:01, HLA-A*11:01, or additional HLA-B/HLA-C requirements).
Submit Your Request
Our team will confirm current donor/lot availability and provide a quote COA documentation.
Please note that availability varies by genotype and donor lot. A selection and verification fee will be applied per vial and reflected in your quote.
For information on available genotypes, assistance selecting the right cells, or inquiries about additional genotypes and cell types, please contact us at info@sciencellonline.com, or call 1.877.602.8549.